Friday 23 February 2018
Contact US    |    Archive
PR
5 months ago

Ocugen Announces FDA Acceptance of Investigational New Drug Application for OCU310 (brimonidine/steroid combination therapy) and Initiates Proof of Concept Study for Treatment of Dry Eye Disease

MALVERN, Pa., Sept. 25, 2017 /PRNewswire/ -- Ocugen, Inc., a clinical stage biopharmaceutical compan

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.

Indian PM receives Al-Faleh

- Saudi News Agency
Hashtags:   

Ocugen

 | 

Announces

 | 

FDA

 | 

Acceptance

 | 

Investigational

 | 

New

 | 

Drug

 | 

Application

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Braga vs Marseille

- espnfc.co

Most Popular (a week)

Categories - Countries
All News
All Countries